Diligence memo · auto-generated · as of July 3, 2026
Sterifre Medical, Inc.
Sterifre Medical, Inc. looks under-valued against its niche peers and is at-risk on financing cadence.
Businessfiled
Sterifre Medical, Inc. operates in Healthtech, based in KIRKLAND.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Sterifre Medical, Inc. has raised $16M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $8.0M on 2019-06-28.
Most recent recorded round closed around 2023-05-15.
Valuation (modeled)modeled
Provath models Sterifre Medical, Inc. at approximately $24M (range $3.9M–$66M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.56× the median modeled value of Series A Healthtech companies in 2022–2024 (190 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 26 months.
Last raise 3.1 yr ago; this sector typically re-raises about every 14 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
The last round was 2.6× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 77% of Healthtech peers (2138 compared).
Modeled value ranks above 47% of those peers.
Closest niche peers: Nayya Health, Inc., Nue Life Health Inc., W Health Studio, Inc., Avant-garde Health, Inc., Kinetik Healthcare Solutions, Inc.
Peoplefiled
12 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.